Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8444954 | European Journal of Cancer | 2013 | 11 Pages |
Abstract
There is a strong association between guideline adherence in adjuvant treatment in BC and survival. PA in clinical trials tended to higher survival rates, but only if guideline-adherent treatment was applied. Patients who do not have access to clinical trials may profit substantially from guideline-adherent adjuvant treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
L. Schwentner, R. Van Ewijk, C. Kurzeder, I. Hoffmann, J. König, R. Kreienberg, M. Blettner, A. Wöckel,